nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—CYP2A6—Nevirapine—acquired immunodeficiency syndrome	0.034	0.0505	CbGbCtD
Tretinoin—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.0236	0.035	CbGbCtD
Tretinoin—CYP2A6—Zidovudine—acquired immunodeficiency syndrome	0.0224	0.0332	CbGbCtD
Tretinoin—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0222	0.0329	CbGbCtD
Tretinoin—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.0222	0.0329	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.021	0.0312	CbGbCtD
Tretinoin—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.021	0.0312	CbGbCtD
Tretinoin—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.02	0.0297	CbGbCtD
Tretinoin—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0182	0.0269	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0182	0.0269	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.0176	0.0262	CbGbCtD
Tretinoin—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.0176	0.0262	CbGbCtD
Tretinoin—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0175	0.0259	CbGbCtD
Tretinoin—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.0168	0.0249	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.0159	0.0237	CbGbCtD
Tretinoin—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.0159	0.0237	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.0159	0.0237	CbGbCtD
Tretinoin—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.0159	0.0237	CbGbCtD
Tretinoin—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0158	0.0234	CbGbCtD
Tretinoin—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0158	0.0234	CbGbCtD
Tretinoin—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.0152	0.0225	CbGbCtD
Tretinoin—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0152	0.0225	CbGbCtD
Tretinoin—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0152	0.0225	CbGbCtD
Tretinoin—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0136	0.0202	CbGbCtD
Tretinoin—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0132	0.0196	CbGbCtD
Tretinoin—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0125	0.0185	CbGbCtD
Tretinoin—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.012	0.0177	CbGbCtD
Tretinoin—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.012	0.0177	CbGbCtD
Tretinoin—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0117	0.0174	CbGbCtD
Tretinoin—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0117	0.0174	CbGbCtD
Tretinoin—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0115	0.0171	CbGbCtD
Tretinoin—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0115	0.0171	CbGbCtD
Tretinoin—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.011	0.0164	CbGbCtD
Tretinoin—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0106	0.0157	CbGbCtD
Tretinoin—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0106	0.0157	CbGbCtD
Tretinoin—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00914	0.0136	CbGbCtD
Tretinoin—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00887	0.0132	CbGbCtD
Tretinoin—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00802	0.0119	CbGbCtD
Tretinoin—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00802	0.0119	CbGbCtD
Tretinoin—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00769	0.0114	CbGbCtD
Tretinoin—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00724	0.0107	CbGbCtD
Tretinoin—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00681	0.0101	CbGbCtD
Tretinoin—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00681	0.0101	CbGbCtD
Tretinoin—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00616	0.00913	CbGbCtD
Tretinoin—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00616	0.00913	CbGbCtD
Tretinoin—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00531	0.00788	CbGbCtD
Tretinoin—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00516	0.00765	CbGbCtD
Tretinoin—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00467	0.00692	CbGbCtD
Tretinoin—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00467	0.00692	CbGbCtD
Tretinoin—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00447	0.00663	CbGbCtD
Tretinoin—GPRC5A—digestive system—acquired immunodeficiency syndrome	0.00301	0.0373	CbGeAlD
Tretinoin—GPRC5A—lung—acquired immunodeficiency syndrome	0.00251	0.0312	CbGeAlD
Tretinoin—RARRES1—skin of body—acquired immunodeficiency syndrome	0.0019	0.0236	CbGeAlD
Tretinoin—CRABP1—retina—acquired immunodeficiency syndrome	0.00161	0.0199	CbGeAlD
Tretinoin—CRABP1—skin of body—acquired immunodeficiency syndrome	0.00141	0.0175	CbGeAlD
Tretinoin—RARRES1—vagina—acquired immunodeficiency syndrome	0.00134	0.0167	CbGeAlD
Tretinoin—CRABP2—skin of body—acquired immunodeficiency syndrome	0.00127	0.0158	CbGeAlD
Tretinoin—RARRES1—lung—acquired immunodeficiency syndrome	0.00127	0.0158	CbGeAlD
Tretinoin—CYP4A11—digestive system—acquired immunodeficiency syndrome	0.00113	0.014	CbGeAlD
Tretinoin—ALDH1A2—blood—acquired immunodeficiency syndrome	0.00111	0.0138	CbGeAlD
Tretinoin—NR0B1—lung—acquired immunodeficiency syndrome	0.00109	0.0136	CbGeAlD
Tretinoin—ALDH1A1—skin of body—acquired immunodeficiency syndrome	0.00106	0.0132	CbGeAlD
Tretinoin—RARG—retina—acquired immunodeficiency syndrome	0.00106	0.0131	CbGeAlD
Tretinoin—CRABP1—spinal cord—acquired immunodeficiency syndrome	0.00103	0.0128	CbGeAlD
Tretinoin—ALDH1A2—vagina—acquired immunodeficiency syndrome	0.00103	0.0128	CbGeAlD
Tretinoin—CRABP2—digestive system—acquired immunodeficiency syndrome	0.00102	0.0126	CbGeAlD
Tretinoin—CRABP1—vagina—acquired immunodeficiency syndrome	0.000995	0.0123	CbGeAlD
Tretinoin—CYP4A11—vagina—acquired immunodeficiency syndrome	0.000995	0.0123	CbGeAlD
Tretinoin—ALDH1A2—lung—acquired immunodeficiency syndrome	0.000976	0.0121	CbGeAlD
Tretinoin—CRABP2—blood—acquired immunodeficiency syndrome	0.000971	0.012	CbGeAlD
Tretinoin—CRABP2—spinal cord—acquired immunodeficiency syndrome	0.000936	0.0116	CbGeAlD
Tretinoin—RARG—skin of body—acquired immunodeficiency syndrome	0.00093	0.0115	CbGeAlD
Tretinoin—ALDH1A2—nervous system—acquired immunodeficiency syndrome	0.000903	0.0112	CbGeAlD
Tretinoin—CRABP2—vagina—acquired immunodeficiency syndrome	0.0009	0.0112	CbGeAlD
Tretinoin—RARRES1—brain—acquired immunodeficiency syndrome	0.0009	0.0112	CbGeAlD
Tretinoin—CRABP1—nervous system—acquired immunodeficiency syndrome	0.000872	0.0108	CbGeAlD
Tretinoin—ALDH1A2—central nervous system—acquired immunodeficiency syndrome	0.00087	0.0108	CbGeAlD
Tretinoin—RARRES1—lymph node—acquired immunodeficiency syndrome	0.00087	0.0108	CbGeAlD
Tretinoin—ALDH1A1—lymphoid tissue—acquired immunodeficiency syndrome	0.00086	0.0107	CbGeAlD
Tretinoin—CRABP2—lung—acquired immunodeficiency syndrome	0.000851	0.0106	CbGeAlD
Tretinoin—ALDH1A1—digestive system—acquired immunodeficiency syndrome	0.000849	0.0105	CbGeAlD
Tretinoin—CRABP1—central nervous system—acquired immunodeficiency syndrome	0.000839	0.0104	CbGeAlD
Tretinoin—RXRG—spinal cord—acquired immunodeficiency syndrome	0.000818	0.0101	CbGeAlD
Tretinoin—ALDH1A1—blood—acquired immunodeficiency syndrome	0.000809	0.01	CbGeAlD
Tretinoin—RARB—vagina—acquired immunodeficiency syndrome	0.000805	0.00998	CbGeAlD
Tretinoin—CRABP2—nervous system—acquired immunodeficiency syndrome	0.000788	0.00977	CbGeAlD
Tretinoin—RXRA—nervous system—acquired immunodeficiency syndrome	0.000785	0.00973	CbGeAlD
Tretinoin—ALDH1A1—bone marrow—acquired immunodeficiency syndrome	0.000783	0.00971	CbGeAlD
Tretinoin—ALDH1A1—spinal cord—acquired immunodeficiency syndrome	0.00078	0.00966	CbGeAlD
Tretinoin—NR0B1—brain—acquired immunodeficiency syndrome	0.000775	0.0096	CbGeAlD
Tretinoin—RARB—lung—acquired immunodeficiency syndrome	0.000761	0.00944	CbGeAlD
Tretinoin—CRABP2—central nervous system—acquired immunodeficiency syndrome	0.000759	0.00941	CbGeAlD
Tretinoin—RXRA—central nervous system—acquired immunodeficiency syndrome	0.000756	0.00937	CbGeAlD
Tretinoin—ALDH1A1—vagina—acquired immunodeficiency syndrome	0.00075	0.0093	CbGeAlD
Tretinoin—CYP2C18—digestive system—acquired immunodeficiency syndrome	0.000747	0.00925	CbGeAlD
Tretinoin—RARG—digestive system—acquired immunodeficiency syndrome	0.000744	0.00922	CbGeAlD
Tretinoin—RXRB—vagina—acquired immunodeficiency syndrome	0.00074	0.00917	CbGeAlD
Tretinoin—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.00072	0.00893	CbGeAlD
Tretinoin—ALDH1A1—lung—acquired immunodeficiency syndrome	0.000709	0.00879	CbGeAlD
Tretinoin—RARG—blood—acquired immunodeficiency syndrome	0.000708	0.00878	CbGeAlD
Tretinoin—RARA—lymphoid tissue—acquired immunodeficiency syndrome	0.000708	0.00877	CbGeAlD
Tretinoin—RXRB—lung—acquired immunodeficiency syndrome	0.0007	0.00867	CbGeAlD
Tretinoin—ALDH1A2—brain—acquired immunodeficiency syndrome	0.000691	0.00856	CbGeAlD
Tretinoin—RXRG—nervous system—acquired immunodeficiency syndrome	0.000689	0.00854	CbGeAlD
Tretinoin—ALDH1A2—lymph node—acquired immunodeficiency syndrome	0.000667	0.00827	CbGeAlD
Tretinoin—CRABP1—brain—acquired immunodeficiency syndrome	0.000666	0.00826	CbGeAlD
Tretinoin—RARA—blood—acquired immunodeficiency syndrome	0.000666	0.00826	CbGeAlD
Tretinoin—RXRG—central nervous system—acquired immunodeficiency syndrome	0.000663	0.00822	CbGeAlD
Tretinoin—CYP2C18—vagina—acquired immunodeficiency syndrome	0.000659	0.00817	CbGeAlD
Tretinoin—ALDH1A1—nervous system—acquired immunodeficiency syndrome	0.000657	0.00814	CbGeAlD
Tretinoin—RARG—vagina—acquired immunodeficiency syndrome	0.000657	0.00814	CbGeAlD
Tretinoin—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.00065	0.00806	CbGeAlD
Tretinoin—RXRB—nervous system—acquired immunodeficiency syndrome	0.000648	0.00803	CbGeAlD
Tretinoin—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000646	0.00801	CbGeAlD
Tretinoin—RARA—bone marrow—acquired immunodeficiency syndrome	0.000644	0.00799	CbGeAlD
Tretinoin—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00064	0.00793	CbGeAlD
Tretinoin—ALDH1A1—central nervous system—acquired immunodeficiency syndrome	0.000632	0.00784	CbGeAlD
Tretinoin—RXRB—central nervous system—acquired immunodeficiency syndrome	0.000624	0.00773	CbGeAlD
Tretinoin—RARG—lung—acquired immunodeficiency syndrome	0.000621	0.0077	CbGeAlD
Tretinoin—CRABP2—brain—acquired immunodeficiency syndrome	0.000603	0.00747	CbGeAlD
Tretinoin—RXRA—brain—acquired immunodeficiency syndrome	0.0006	0.00744	CbGeAlD
Tretinoin—RARA—lung—acquired immunodeficiency syndrome	0.000584	0.00724	CbGeAlD
Tretinoin—RARG—nervous system—acquired immunodeficiency syndrome	0.000575	0.00713	CbGeAlD
Tretinoin—RARG—central nervous system—acquired immunodeficiency syndrome	0.000554	0.00686	CbGeAlD
Tretinoin—RARA—nervous system—acquired immunodeficiency syndrome	0.000541	0.0067	CbGeAlD
Tretinoin—RARB—brain—acquired immunodeficiency syndrome	0.000539	0.00668	CbGeAlD
Tretinoin—RXRG—brain—acquired immunodeficiency syndrome	0.000527	0.00653	CbGeAlD
Tretinoin—RARB—lymph node—acquired immunodeficiency syndrome	0.000521	0.00645	CbGeAlD
Tretinoin—RARA—central nervous system—acquired immunodeficiency syndrome	0.000521	0.00645	CbGeAlD
Tretinoin—ALDH1A1—brain—acquired immunodeficiency syndrome	0.000502	0.00622	CbGeAlD
Tretinoin—RXRB—brain—acquired immunodeficiency syndrome	0.000495	0.00614	CbGeAlD
Tretinoin—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000488	0.00605	CbGeAlD
Tretinoin—ALDH1A1—lymph node—acquired immunodeficiency syndrome	0.000485	0.00601	CbGeAlD
Tretinoin—RARG—brain—acquired immunodeficiency syndrome	0.00044	0.00545	CbGeAlD
Tretinoin—Acitretin—ALB—acquired immunodeficiency syndrome	0.000439	1	CrCbGaD
Tretinoin—CYP2A6—vagina—acquired immunodeficiency syndrome	0.000436	0.0054	CbGeAlD
Tretinoin—RARG—lymph node—acquired immunodeficiency syndrome	0.000425	0.00526	CbGeAlD
Tretinoin—RARA—brain—acquired immunodeficiency syndrome	0.000413	0.00512	CbGeAlD
Tretinoin—CYP2A6—lung—acquired immunodeficiency syndrome	0.000412	0.00511	CbGeAlD
Tretinoin—RARA—lymph node—acquired immunodeficiency syndrome	0.000399	0.00495	CbGeAlD
Tretinoin—CYP1A1—skin of body—acquired immunodeficiency syndrome	0.00032	0.00396	CbGeAlD
Tretinoin—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000311	0.00385	CbGeAlD
Tretinoin—CYP2A6—brain—acquired immunodeficiency syndrome	0.000292	0.00362	CbGeAlD
Tretinoin—CYP2C8—blood—acquired immunodeficiency syndrome	0.000264	0.00327	CbGeAlD
Tretinoin—CYP1A1—digestive system—acquired immunodeficiency syndrome	0.000256	0.00317	CbGeAlD
Tretinoin—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000252	0.00312	CbGeAlD
Tretinoin—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.00025	0.0031	CbGeAlD
Tretinoin—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000248	0.00308	CbGeAlD
Tretinoin—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000246	0.00305	CbGeAlD
Tretinoin—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000245	0.00303	CbGeAlD
Tretinoin—CYP1A1—blood—acquired immunodeficiency syndrome	0.000244	0.00302	CbGeAlD
Tretinoin—CYP3A5—blood—acquired immunodeficiency syndrome	0.000238	0.00295	CbGeAlD
Tretinoin—CYP2B6—blood—acquired immunodeficiency syndrome	0.000237	0.00293	CbGeAlD
Tretinoin—CYP2C9—blood—acquired immunodeficiency syndrome	0.000234	0.00291	CbGeAlD
Tretinoin—CYP1A1—vagina—acquired immunodeficiency syndrome	0.000226	0.0028	CbGeAlD
Tretinoin—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000221	0.00274	CbGeAlD
Tretinoin—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000219	0.00272	CbGeAlD
Tretinoin—CYP1A1—lung—acquired immunodeficiency syndrome	0.000214	0.00265	CbGeAlD
Tretinoin—CYP3A5—lung—acquired immunodeficiency syndrome	0.000209	0.00259	CbGeAlD
Tretinoin—CYP2B6—lung—acquired immunodeficiency syndrome	0.000208	0.00257	CbGeAlD
Tretinoin—CYP1A1—nervous system—acquired immunodeficiency syndrome	0.000198	0.00245	CbGeAlD
Tretinoin—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000192	0.00238	CbGeAlD
Tretinoin—CYP1A1—central nervous system—acquired immunodeficiency syndrome	0.00019	0.00236	CbGeAlD
Tretinoin—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000188	0.00233	CbGeAlD
Tretinoin—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000185	0.00229	CbGeAlD
Tretinoin—CYP3A4—blood—acquired immunodeficiency syndrome	0.000179	0.00222	CbGeAlD
Tretinoin—CYP2C8—brain—acquired immunodeficiency syndrome	0.000164	0.00203	CbGeAlD
Tretinoin—CYP1A1—brain—acquired immunodeficiency syndrome	0.000151	0.00187	CbGeAlD
Tretinoin—CYP2B6—brain—acquired immunodeficiency syndrome	0.000147	0.00182	CbGeAlD
Tretinoin—CYP1A1—lymph node—acquired immunodeficiency syndrome	0.000146	0.00181	CbGeAlD
Tretinoin—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000145	0.0018	CbGeAlD
Tretinoin—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.00014	0.00173	CbGeAlD
Tretinoin—Anaemia—Lamivudine—acquired immunodeficiency syndrome	6.82e-05	0.000279	CcSEcCtD
Tretinoin—Anxiety—Ritonavir—acquired immunodeficiency syndrome	6.82e-05	0.000279	CcSEcCtD
Tretinoin—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	6.8e-05	0.000278	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	6.8e-05	0.000278	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	6.78e-05	0.000277	CcSEcCtD
Tretinoin—Pruritus—Abacavir—acquired immunodeficiency syndrome	6.77e-05	0.000277	CcSEcCtD
Tretinoin—Fatigue—Indinavir—acquired immunodeficiency syndrome	6.77e-05	0.000277	CcSEcCtD
Tretinoin—Anorexia—Delavirdine—acquired immunodeficiency syndrome	6.76e-05	0.000276	CcSEcCtD
Tretinoin—Discomfort—Ritonavir—acquired immunodeficiency syndrome	6.76e-05	0.000276	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	6.76e-05	0.000276	CcSEcCtD
Tretinoin—Cough—Saquinavir—acquired immunodeficiency syndrome	6.75e-05	0.000276	CcSEcCtD
Tretinoin—Constipation—Indinavir—acquired immunodeficiency syndrome	6.71e-05	0.000274	CcSEcCtD
Tretinoin—Pain—Indinavir—acquired immunodeficiency syndrome	6.71e-05	0.000274	CcSEcCtD
Tretinoin—Insomnia—Efavirenz—acquired immunodeficiency syndrome	6.71e-05	0.000274	CcSEcCtD
Tretinoin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	6.7e-05	0.000274	CcSEcCtD
Tretinoin—Convulsion—Saquinavir—acquired immunodeficiency syndrome	6.7e-05	0.000274	CcSEcCtD
Tretinoin—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	6.69e-05	0.000274	CcSEcCtD
Tretinoin—Hypertension—Saquinavir—acquired immunodeficiency syndrome	6.68e-05	0.000273	CcSEcCtD
Tretinoin—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	6.67e-05	0.000273	CcSEcCtD
Tretinoin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	6.67e-05	0.000273	CcSEcCtD
Tretinoin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	6.66e-05	0.000272	CcSEcCtD
Tretinoin—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	6.66e-05	0.000272	CcSEcCtD
Tretinoin—Malaise—Lamivudine—acquired immunodeficiency syndrome	6.66e-05	0.000272	CcSEcCtD
Tretinoin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	6.64e-05	0.000271	CcSEcCtD
Tretinoin—Nausea—Didanosine—acquired immunodeficiency syndrome	6.64e-05	0.000271	CcSEcCtD
Tretinoin—Hypotension—Delavirdine—acquired immunodeficiency syndrome	6.63e-05	0.000271	CcSEcCtD
Tretinoin—Syncope—Lamivudine—acquired immunodeficiency syndrome	6.62e-05	0.000271	CcSEcCtD
Tretinoin—Confusional state—Ritonavir—acquired immunodeficiency syndrome	6.62e-05	0.00027	CcSEcCtD
Tretinoin—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	6.61e-05	0.00027	CcSEcCtD
Tretinoin—Somnolence—Efavirenz—acquired immunodeficiency syndrome	6.59e-05	0.000269	CcSEcCtD
Tretinoin—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	6.59e-05	0.000269	CcSEcCtD
Tretinoin—Chest pain—Saquinavir—acquired immunodeficiency syndrome	6.59e-05	0.000269	CcSEcCtD
Tretinoin—Myalgia—Saquinavir—acquired immunodeficiency syndrome	6.59e-05	0.000269	CcSEcCtD
Tretinoin—Anxiety—Saquinavir—acquired immunodeficiency syndrome	6.56e-05	0.000268	CcSEcCtD
Tretinoin—Oedema—Ritonavir—acquired immunodeficiency syndrome	6.56e-05	0.000268	CcSEcCtD
Tretinoin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	6.54e-05	0.000267	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	6.54e-05	0.000267	CcSEcCtD
Tretinoin—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	6.53e-05	0.000267	CcSEcCtD
Tretinoin—Discomfort—Saquinavir—acquired immunodeficiency syndrome	6.51e-05	0.000266	CcSEcCtD
Tretinoin—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	6.49e-05	0.000265	CcSEcCtD
Tretinoin—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	6.47e-05	0.000264	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	6.46e-05	0.000264	CcSEcCtD
Tretinoin—Shock—Ritonavir—acquired immunodeficiency syndrome	6.46e-05	0.000264	CcSEcCtD
Tretinoin—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	6.45e-05	0.000263	CcSEcCtD
Tretinoin—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	6.44e-05	0.000263	CcSEcCtD
Tretinoin—Cough—Lamivudine—acquired immunodeficiency syndrome	6.44e-05	0.000263	CcSEcCtD
Tretinoin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	6.44e-05	0.000263	CcSEcCtD
Tretinoin—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	6.43e-05	0.000263	CcSEcCtD
Tretinoin—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	6.42e-05	0.000263	CcSEcCtD
Tretinoin—Dizziness—Stavudine—acquired immunodeficiency syndrome	6.42e-05	0.000262	CcSEcCtD
Tretinoin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	6.42e-05	0.000262	CcSEcCtD
Tretinoin—Insomnia—Delavirdine—acquired immunodeficiency syndrome	6.42e-05	0.000262	CcSEcCtD
Tretinoin—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	6.4e-05	0.000262	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	6.4e-05	0.000262	CcSEcCtD
Tretinoin—Convulsion—Lamivudine—acquired immunodeficiency syndrome	6.4e-05	0.000261	CcSEcCtD
Tretinoin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	6.39e-05	0.000261	CcSEcCtD
Tretinoin—Fatigue—Efavirenz—acquired immunodeficiency syndrome	6.39e-05	0.000261	CcSEcCtD
Tretinoin—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	6.37e-05	0.00026	CcSEcCtD
Tretinoin—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	6.37e-05	0.00026	CcSEcCtD
Tretinoin—Confusional state—Saquinavir—acquired immunodeficiency syndrome	6.37e-05	0.00026	CcSEcCtD
Tretinoin—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	6.34e-05	0.000259	CcSEcCtD
Tretinoin—Pain—Efavirenz—acquired immunodeficiency syndrome	6.34e-05	0.000259	CcSEcCtD
Tretinoin—Constipation—Efavirenz—acquired immunodeficiency syndrome	6.34e-05	0.000259	CcSEcCtD
Tretinoin—Rash—Nevirapine—acquired immunodeficiency syndrome	6.34e-05	0.000259	CcSEcCtD
Tretinoin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	6.33e-05	0.000259	CcSEcCtD
Tretinoin—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	6.33e-05	0.000258	CcSEcCtD
Tretinoin—Dizziness—Abacavir—acquired immunodeficiency syndrome	6.33e-05	0.000258	CcSEcCtD
Tretinoin—Oedema—Saquinavir—acquired immunodeficiency syndrome	6.32e-05	0.000258	CcSEcCtD
Tretinoin—Somnolence—Delavirdine—acquired immunodeficiency syndrome	6.31e-05	0.000258	CcSEcCtD
Tretinoin—Headache—Nevirapine—acquired immunodeficiency syndrome	6.3e-05	0.000257	CcSEcCtD
Tretinoin—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	6.28e-05	0.000257	CcSEcCtD
Tretinoin—Myalgia—Lamivudine—acquired immunodeficiency syndrome	6.28e-05	0.000257	CcSEcCtD
Tretinoin—Chest pain—Lamivudine—acquired immunodeficiency syndrome	6.28e-05	0.000257	CcSEcCtD
Tretinoin—Infection—Saquinavir—acquired immunodeficiency syndrome	6.27e-05	0.000256	CcSEcCtD
Tretinoin—Anxiety—Lamivudine—acquired immunodeficiency syndrome	6.26e-05	0.000256	CcSEcCtD
Tretinoin—Anorexia—Ritonavir—acquired immunodeficiency syndrome	6.25e-05	0.000256	CcSEcCtD
Tretinoin—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	6.25e-05	0.000255	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	6.24e-05	0.000255	CcSEcCtD
Tretinoin—Urticaria—Indinavir—acquired immunodeficiency syndrome	6.24e-05	0.000255	CcSEcCtD
Tretinoin—Shock—Saquinavir—acquired immunodeficiency syndrome	6.21e-05	0.000254	CcSEcCtD
Tretinoin—Discomfort—Lamivudine—acquired immunodeficiency syndrome	6.21e-05	0.000254	CcSEcCtD
Tretinoin—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	6.2e-05	0.000254	CcSEcCtD
Tretinoin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	6.2e-05	0.000254	CcSEcCtD
Tretinoin—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	6.19e-05	0.000253	CcSEcCtD
Tretinoin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	6.19e-05	0.000253	CcSEcCtD
Tretinoin—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	6.18e-05	0.000253	CcSEcCtD
Tretinoin—Vomiting—Stavudine—acquired immunodeficiency syndrome	6.17e-05	0.000252	CcSEcCtD
Tretinoin—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	6.17e-05	0.000252	CcSEcCtD
Tretinoin—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	6.15e-05	0.000251	CcSEcCtD
Tretinoin—Rash—Nelfinavir—acquired immunodeficiency syndrome	6.14e-05	0.000251	CcSEcCtD
Tretinoin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	6.14e-05	0.000251	CcSEcCtD
Tretinoin—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	6.13e-05	0.000251	CcSEcCtD
Tretinoin—Hypotension—Ritonavir—acquired immunodeficiency syndrome	6.13e-05	0.000251	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	6.13e-05	0.00025	CcSEcCtD
Tretinoin—Rash—Stavudine—acquired immunodeficiency syndrome	6.12e-05	0.00025	CcSEcCtD
Tretinoin—Fatigue—Delavirdine—acquired immunodeficiency syndrome	6.12e-05	0.00025	CcSEcCtD
Tretinoin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	6.12e-05	0.00025	CcSEcCtD
Tretinoin—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	6.11e-05	0.00025	CcSEcCtD
Tretinoin—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	6.11e-05	0.000249	CcSEcCtD
Tretinoin—Headache—Nelfinavir—acquired immunodeficiency syndrome	6.1e-05	0.000249	CcSEcCtD
Tretinoin—Headache—Stavudine—acquired immunodeficiency syndrome	6.08e-05	0.000249	CcSEcCtD
Tretinoin—Vomiting—Abacavir—acquired immunodeficiency syndrome	6.08e-05	0.000249	CcSEcCtD
Tretinoin—Confusional state—Lamivudine—acquired immunodeficiency syndrome	6.07e-05	0.000248	CcSEcCtD
Tretinoin—Constipation—Delavirdine—acquired immunodeficiency syndrome	6.07e-05	0.000248	CcSEcCtD
Tretinoin—Pain—Delavirdine—acquired immunodeficiency syndrome	6.07e-05	0.000248	CcSEcCtD
Tretinoin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	6.06e-05	0.000248	CcSEcCtD
Tretinoin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	6.06e-05	0.000247	CcSEcCtD
Tretinoin—Rash—Abacavir—acquired immunodeficiency syndrome	6.03e-05	0.000246	CcSEcCtD
Tretinoin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	6.03e-05	0.000246	CcSEcCtD
Tretinoin—Oedema—Lamivudine—acquired immunodeficiency syndrome	6.02e-05	0.000246	CcSEcCtD
Tretinoin—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	6.02e-05	0.000246	CcSEcCtD
Tretinoin—Anorexia—Saquinavir—acquired immunodeficiency syndrome	6.02e-05	0.000246	CcSEcCtD
Tretinoin—Headache—Abacavir—acquired immunodeficiency syndrome	5.99e-05	0.000245	CcSEcCtD
Tretinoin—Infection—Lamivudine—acquired immunodeficiency syndrome	5.99e-05	0.000245	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	5.98e-05	0.000244	CcSEcCtD
Tretinoin—Nausea—Nevirapine—acquired immunodeficiency syndrome	5.97e-05	0.000244	CcSEcCtD
Tretinoin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	5.97e-05	0.000244	CcSEcCtD
Tretinoin—Insomnia—Ritonavir—acquired immunodeficiency syndrome	5.93e-05	0.000243	CcSEcCtD
Tretinoin—Shock—Lamivudine—acquired immunodeficiency syndrome	5.93e-05	0.000242	CcSEcCtD
Tretinoin—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	5.91e-05	0.000241	CcSEcCtD
Tretinoin—Hypotension—Saquinavir—acquired immunodeficiency syndrome	5.9e-05	0.000241	CcSEcCtD
Tretinoin—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	5.9e-05	0.000241	CcSEcCtD
Tretinoin—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	5.89e-05	0.000241	CcSEcCtD
Tretinoin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	5.89e-05	0.000241	CcSEcCtD
Tretinoin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	5.86e-05	0.00024	CcSEcCtD
Tretinoin—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	5.86e-05	0.00024	CcSEcCtD
Tretinoin—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	5.85e-05	0.000239	CcSEcCtD
Tretinoin—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	5.85e-05	0.000239	CcSEcCtD
Tretinoin—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	5.85e-05	0.000239	CcSEcCtD
Tretinoin—Somnolence—Ritonavir—acquired immunodeficiency syndrome	5.83e-05	0.000238	CcSEcCtD
Tretinoin—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	5.82e-05	0.000238	CcSEcCtD
Tretinoin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	5.8e-05	0.000237	CcSEcCtD
Tretinoin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	5.79e-05	0.000236	CcSEcCtD
Tretinoin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	5.78e-05	0.000236	CcSEcCtD
Tretinoin—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	5.78e-05	0.000236	CcSEcCtD
Tretinoin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	5.77e-05	0.000236	CcSEcCtD
Tretinoin—Nausea—Stavudine—acquired immunodeficiency syndrome	5.77e-05	0.000236	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	5.75e-05	0.000235	CcSEcCtD
Tretinoin—Anorexia—Lamivudine—acquired immunodeficiency syndrome	5.74e-05	0.000235	CcSEcCtD
Tretinoin—Insomnia—Saquinavir—acquired immunodeficiency syndrome	5.71e-05	0.000233	CcSEcCtD
Tretinoin—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	5.7e-05	0.000233	CcSEcCtD
Tretinoin—Nausea—Abacavir—acquired immunodeficiency syndrome	5.68e-05	0.000232	CcSEcCtD
Tretinoin—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	5.67e-05	0.000232	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	5.66e-05	0.000231	CcSEcCtD
Tretinoin—Fatigue—Ritonavir—acquired immunodeficiency syndrome	5.66e-05	0.000231	CcSEcCtD
Tretinoin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	5.64e-05	0.00023	CcSEcCtD
Tretinoin—Asthenia—Indinavir—acquired immunodeficiency syndrome	5.63e-05	0.00023	CcSEcCtD
Tretinoin—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	5.63e-05	0.00023	CcSEcCtD
Tretinoin—Hypotension—Lamivudine—acquired immunodeficiency syndrome	5.63e-05	0.00023	CcSEcCtD
Tretinoin—Somnolence—Saquinavir—acquired immunodeficiency syndrome	5.61e-05	0.000229	CcSEcCtD
Tretinoin—Constipation—Ritonavir—acquired immunodeficiency syndrome	5.61e-05	0.000229	CcSEcCtD
Tretinoin—Pain—Ritonavir—acquired immunodeficiency syndrome	5.61e-05	0.000229	CcSEcCtD
Tretinoin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	5.61e-05	0.000229	CcSEcCtD
Tretinoin—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	5.61e-05	0.000229	CcSEcCtD
Tretinoin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	5.58e-05	0.000228	CcSEcCtD
Tretinoin—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	5.56e-05	0.000227	CcSEcCtD
Tretinoin—Pruritus—Indinavir—acquired immunodeficiency syndrome	5.55e-05	0.000227	CcSEcCtD
Tretinoin—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	5.49e-05	0.000224	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	5.49e-05	0.000224	CcSEcCtD
Tretinoin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	5.46e-05	0.000223	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	5.45e-05	0.000223	CcSEcCtD
Tretinoin—Insomnia—Lamivudine—acquired immunodeficiency syndrome	5.45e-05	0.000223	CcSEcCtD
Tretinoin—Fatigue—Saquinavir—acquired immunodeficiency syndrome	5.44e-05	0.000222	CcSEcCtD
Tretinoin—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	5.41e-05	0.000221	CcSEcCtD
Tretinoin—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	5.41e-05	0.000221	CcSEcCtD
Tretinoin—Pain—Saquinavir—acquired immunodeficiency syndrome	5.4e-05	0.000221	CcSEcCtD
Tretinoin—Constipation—Saquinavir—acquired immunodeficiency syndrome	5.4e-05	0.000221	CcSEcCtD
Tretinoin—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	5.37e-05	0.000219	CcSEcCtD
Tretinoin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	5.37e-05	0.000219	CcSEcCtD
Tretinoin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	5.37e-05	0.000219	CcSEcCtD
Tretinoin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	5.37e-05	0.000219	CcSEcCtD
Tretinoin—Somnolence—Lamivudine—acquired immunodeficiency syndrome	5.36e-05	0.000219	CcSEcCtD
Tretinoin—Rash—Zidovudine—acquired immunodeficiency syndrome	5.32e-05	0.000217	CcSEcCtD
Tretinoin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	5.32e-05	0.000217	CcSEcCtD
Tretinoin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	5.32e-05	0.000217	CcSEcCtD
Tretinoin—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	5.3e-05	0.000217	CcSEcCtD
Tretinoin—Headache—Zidovudine—acquired immunodeficiency syndrome	5.29e-05	0.000216	CcSEcCtD
Tretinoin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	5.25e-05	0.000214	CcSEcCtD
Tretinoin—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	5.24e-05	0.000214	CcSEcCtD
Tretinoin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	5.23e-05	0.000214	CcSEcCtD
Tretinoin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	5.21e-05	0.000213	CcSEcCtD
Tretinoin—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	5.2e-05	0.000213	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	5.2e-05	0.000213	CcSEcCtD
Tretinoin—Fatigue—Lamivudine—acquired immunodeficiency syndrome	5.19e-05	0.000212	CcSEcCtD
Tretinoin—Dizziness—Indinavir—acquired immunodeficiency syndrome	5.19e-05	0.000212	CcSEcCtD
Tretinoin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	5.19e-05	0.000212	CcSEcCtD
Tretinoin—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	5.19e-05	0.000212	CcSEcCtD
Tretinoin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	5.16e-05	0.000211	CcSEcCtD
Tretinoin—Constipation—Lamivudine—acquired immunodeficiency syndrome	5.15e-05	0.000211	CcSEcCtD
Tretinoin—Pain—Lamivudine—acquired immunodeficiency syndrome	5.15e-05	0.000211	CcSEcCtD
Tretinoin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	5.09e-05	0.000208	CcSEcCtD
Tretinoin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	5.07e-05	0.000207	CcSEcCtD
Tretinoin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	5.02e-05	0.000205	CcSEcCtD
Tretinoin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	5.02e-05	0.000205	CcSEcCtD
Tretinoin—Nausea—Zidovudine—acquired immunodeficiency syndrome	5.01e-05	0.000205	CcSEcCtD
Tretinoin—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	4.99e-05	0.000204	CcSEcCtD
Tretinoin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	4.99e-05	0.000204	CcSEcCtD
Tretinoin—Vomiting—Indinavir—acquired immunodeficiency syndrome	4.99e-05	0.000204	CcSEcCtD
Tretinoin—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	4.96e-05	0.000203	CcSEcCtD
Tretinoin—Rash—Indinavir—acquired immunodeficiency syndrome	4.95e-05	0.000202	CcSEcCtD
Tretinoin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	4.94e-05	0.000202	CcSEcCtD
Tretinoin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	4.93e-05	0.000201	CcSEcCtD
Tretinoin—Headache—Indinavir—acquired immunodeficiency syndrome	4.92e-05	0.000201	CcSEcCtD
Tretinoin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	4.9e-05	0.0002	CcSEcCtD
Tretinoin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	4.85e-05	0.000198	CcSEcCtD
Tretinoin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	4.83e-05	0.000198	CcSEcCtD
Tretinoin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	4.79e-05	0.000196	CcSEcCtD
Tretinoin—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	4.76e-05	0.000195	CcSEcCtD
Tretinoin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	4.76e-05	0.000195	CcSEcCtD
Tretinoin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	4.71e-05	0.000193	CcSEcCtD
Tretinoin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	4.71e-05	0.000192	CcSEcCtD
Tretinoin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	4.69e-05	0.000192	CcSEcCtD
Tretinoin—Rash—Efavirenz—acquired immunodeficiency syndrome	4.68e-05	0.000191	CcSEcCtD
Tretinoin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	4.67e-05	0.000191	CcSEcCtD
Tretinoin—Nausea—Indinavir—acquired immunodeficiency syndrome	4.66e-05	0.000191	CcSEcCtD
Tretinoin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	4.65e-05	0.00019	CcSEcCtD
Tretinoin—Headache—Efavirenz—acquired immunodeficiency syndrome	4.65e-05	0.00019	CcSEcCtD
Tretinoin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	4.64e-05	0.00019	CcSEcCtD
Tretinoin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	4.53e-05	0.000185	CcSEcCtD
Tretinoin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	4.51e-05	0.000184	CcSEcCtD
Tretinoin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	4.49e-05	0.000183	CcSEcCtD
Tretinoin—Rash—Delavirdine—acquired immunodeficiency syndrome	4.47e-05	0.000183	CcSEcCtD
Tretinoin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	4.47e-05	0.000183	CcSEcCtD
Tretinoin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	4.47e-05	0.000183	CcSEcCtD
Tretinoin—Headache—Delavirdine—acquired immunodeficiency syndrome	4.44e-05	0.000182	CcSEcCtD
Tretinoin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	4.44e-05	0.000181	CcSEcCtD
Tretinoin—Nausea—Efavirenz—acquired immunodeficiency syndrome	4.4e-05	0.00018	CcSEcCtD
Tretinoin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	4.34e-05	0.000177	CcSEcCtD
Tretinoin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	4.32e-05	0.000177	CcSEcCtD
Tretinoin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	4.32e-05	0.000177	CcSEcCtD
Tretinoin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	4.26e-05	0.000174	CcSEcCtD
Tretinoin—Nausea—Delavirdine—acquired immunodeficiency syndrome	4.21e-05	0.000172	CcSEcCtD
Tretinoin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	4.18e-05	0.000171	CcSEcCtD
Tretinoin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	4.17e-05	0.00017	CcSEcCtD
Tretinoin—Rash—Ritonavir—acquired immunodeficiency syndrome	4.14e-05	0.000169	CcSEcCtD
Tretinoin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	4.13e-05	0.000169	CcSEcCtD
Tretinoin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	4.12e-05	0.000168	CcSEcCtD
Tretinoin—Headache—Ritonavir—acquired immunodeficiency syndrome	4.11e-05	0.000168	CcSEcCtD
Tretinoin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	4.02e-05	0.000164	CcSEcCtD
Tretinoin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	3.98e-05	0.000163	CcSEcCtD
Tretinoin—Rash—Saquinavir—acquired immunodeficiency syndrome	3.98e-05	0.000163	CcSEcCtD
Tretinoin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	3.98e-05	0.000163	CcSEcCtD
Tretinoin—Headache—Saquinavir—acquired immunodeficiency syndrome	3.96e-05	0.000162	CcSEcCtD
Tretinoin—Nausea—Ritonavir—acquired immunodeficiency syndrome	3.9e-05	0.000159	CcSEcCtD
Tretinoin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	3.83e-05	0.000157	CcSEcCtD
Tretinoin—Rash—Lamivudine—acquired immunodeficiency syndrome	3.8e-05	0.000155	CcSEcCtD
Tretinoin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	3.8e-05	0.000155	CcSEcCtD
Tretinoin—Headache—Lamivudine—acquired immunodeficiency syndrome	3.77e-05	0.000154	CcSEcCtD
Tretinoin—Nausea—Saquinavir—acquired immunodeficiency syndrome	3.75e-05	0.000153	CcSEcCtD
Tretinoin—Nausea—Lamivudine—acquired immunodeficiency syndrome	3.58e-05	0.000146	CcSEcCtD
